Pain, sedation and morphine metabolism in cancer patients during long-term treatment with sustained-release morphine

Research output: Contribution to journalJournal articleResearchpeer-review

Morphine-6-glucuronide (M-6-G) and morphine-3-glucuronide (M-3-G) are the two most important metabolites of morphine. Both are pharmacologically active, however, with different effects. M-6-G has been demonstrated capable of inducing anti-nociception and sedation, and M-3-G may induce behavioural excitation and possibly antagonise anti-nociception. Their impact on pharmacodynamics in patients in long-term treatment with oral morphine remains to be settled.
Original languageEnglish
JournalPalliative Medicine
Volume16
Issue number2
Pages (from-to)107-14
Number of pages8
ISSN0269-2163
Publication statusPublished - Mar 2002
Externally publishedYes

    Research areas

  • Adult, Aged, Analgesics, Opioid, Delayed-Action Preparations, Female, Humans, Male, Middle Aged, Morphine, Morphine Derivatives, Neoplasms, Pain

ID: 46099227